Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen amgen Retirement and Savings Plan (U.S. Form 11-K) — Net Assets Available for Benefits ($M) ($M)
Form 11-K Amgen Retirement and Savings Plan (U.S.)
Latest, FY2025
8,963
Period ended Dec 31, 2025
Change on a year earlier
+15.6%
7,755 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up amgen retirement and savings plan (u.s. form 11-k) — net assets available for benefits ($m)
- U.S. Plan — Investments at Fair Value ($M)8,166 · FY2025
- U.S. Plan — Benefit-Responsive Investment Contracts at Contract Value ($M)761 · FY2025
- U.S. Plan — Amgen Inc. Common Stock Held in Plan ($M)418 · FY2025
- U.S. Plan — Notes Receivable from Participants ($M)39.1 · FY2025
- U.S. Plan — Employer Contributions ($M)288 · FY2025
- U.S. Plan — Participant Contributions ($M)254 · FY2025
- U.S. Plan — Participant Rollover Contributions ($M)45.4 · FY2025
- U.S. Plan — Dividend and Interest Income ($M)58.9 · FY2025
- U.S. Plan — Net Realized and Unrealized Gains (Losses) on Investments ($M)1,208 · FY2025
- U.S. Plan — Benefits Paid to Participants ($M)641 · FY2025
- U.S. Plan — Administrative and Investment Management Expenses ($M)8.19 · FY2025
Cite this data
StockData. (2026). Amgen Amgen Retirement and Savings Plan (U.S. Form 11-K) — Net Assets Available for Benefits ($M) ($M), annual FY2017–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/plan_us_net_assets
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.